Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06370637Not ApplicableNot Yet Recruiting

Testing a Novel Barrier Cream for Fecal Incontinence in an Ambulatory Population

Role: lead

NCT06221046Not ApplicableNot Yet Recruiting

Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage

Role: lead

NCT05760469Not ApplicableNot Yet Recruiting

Seeing Red: Clinical Assessment Tools for Clinical Trial Decision Support

Role: lead

All 3 trials loaded